Harvest Fund Management Co. Ltd purchased a new stake in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 12,947 shares of the company’s stock, valued at approximately $424,000.
A number of other hedge funds also recently modified their holdings of ARKG. Naples Money Management LLC acquired a new stake in ARK Genomic Revolution ETF during the fourth quarter valued at approximately $63,000. Sloy Dahl & Holst LLC increased its stake in shares of ARK Genomic Revolution ETF by 18.2% in the fourth quarter. Sloy Dahl & Holst LLC now owns 13,492 shares of the company’s stock valued at $443,000 after buying an additional 2,079 shares in the last quarter. Elmwood Wealth Management Inc. bought a new position in shares of ARK Genomic Revolution ETF in the fourth quarter valued at about $302,000. DHK Financial Advisors Inc. grew its holdings in ARK Genomic Revolution ETF by 124.2% during the 4th quarter. DHK Financial Advisors Inc. now owns 44,410 shares of the company’s stock worth $1,457,000 after acquiring an additional 24,600 shares during the last quarter. Finally, Perigon Wealth Management LLC lifted its holdings in ARK Genomic Revolution ETF by 12.9% during the 4th quarter. Perigon Wealth Management LLC now owns 29,583 shares of the company’s stock worth $971,000 after buying an additional 3,380 shares in the last quarter.
ARK Genomic Revolution ETF Stock Down 1.3 %
ARK Genomic Revolution ETF stock traded down $0.30 during mid-day trading on Wednesday, hitting $23.68. The stock had a trading volume of 2,538,687 shares. The firm’s 50 day moving average is $28.54 and its 200-day moving average is $28.43.
ARK Genomic Revolution ETF Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Featured Stories
- Five stocks we like better than ARK Genomic Revolution ETF
- Consumer Discretionary Stocks Explained
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to Use the MarketBeat Dividend Calculator
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
